Group 1 - The market focus is on stocks like Yong'an Pharmaceutical, which has seen a 2.44% decline after 11 consecutive trading days with 7 gains [1] - Youfu Co. experienced a 5.24% drop, while Meibang Co. saw a 6.14% decline, both after multiple days of gains [1] - Binhai Energy, involved in mergers and acquisitions, opened down 3.80% after 8 days with 6 gains [1] Group 2 - Nuclear power stocks such as Shangwei Co. opened up 4.97% after 5 consecutive gains, while Rongfa Nuclear Power opened up 3.74% after 4 gains [1] - Autonomous logistics vehicle stocks, including Tongda Electric and Yunnei Power, both reached their daily limit up, with Tongda Electric gaining 10.03% and Yunnei Power gaining 10.10% [1][2] - New consumption stocks like Huaiqi Mountain opened down 2.71%, while Junyao Health reached its daily limit up with a gain of 10.05% [1][2] Group 3 - Gold concept stocks such as Mingpai Jewelry opened down 0.67% after recent trading activity [1][2]

Group 1 - The overall market liquidity remains tight, with structural market conditions leading to rotations in new consumption and new manufacturing sectors [1][18] - There are left-side investment opportunities in fields such as robotics, intelligent driving, and internet platforms [1][18] - The basic chemical industry is currently undervalued, presenting medium to long-term investment potential [18] Group 2 - The performance of sectors like consumption and pharmaceuticals is expected to be relatively stable, with short-term elasticity likely to be better [18] - The chemical industry is anticipated to see structural opportunities and valuation recovery in 2025, driven by policy stimulus and improving demand [18] - The supply side of the chemical industry is experiencing a slowdown in capital expenditure and new capacity growth, which will take time to digest [18]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 重要风险提示： 1、潜江永安药业股份有限公司（以下简称"公司"，证券简称：永安药业，证券代码：002365）股票交 易于2025年5月15日至2025年5月28日连续十个交易日内收盘价格涨幅偏离值累计超过100%，根据深圳 证券交易所的有关规定，属于股票交易严重异常波动情形。 2、近期公司股价短期涨幅较大，已严重偏离公司基本面，存在较高的炒作风险。公司不存在应披露未 披露的重大信息。2025年一季度，公司处于亏损状态。公司特别提醒投资者，注意投资风险，理性决 策，审慎投资。 3、截至本公告披露时，中证指数有限公司的最新数据显示，公司的静态市盈率为106.82，滚动市盈率 为229.74，市净率为3.34；公司所属中上协行业分类"医药制造业"的静态市盈率为28.22，滚动市盈率为 27.74，市净率为2.72。公司静态市盈率、滚动市盈率、市净率均高于公司所属中上协行业分类"医药制 造业"水平。公司已连续多日发布股票交易异常波动公告，特别提醒广大投资者注意二级市场交易 ...

Group 1 - China Energy Engineering announced that its subsidiary, China Power Engineering Consulting Group Northwest Electric Power Design Institute, has won a bid for a coal power project with a contract value of approximately 14.586 billion yuan [1] - Hehe Information plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its global strategy and brand recognition [2] - Jiaying Pharmaceutical is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [3] Group 2 - Longgao Co. received notice of a restructuring involving its controlling shareholder, Longyan Investment Development Group, which will become a wholly-owned subsidiary of the newly established Longyan Investment Development Group with a registered capital of 3 billion yuan [4] - Fuda Co. signed an investment agreement to build a precision gear project for electric drive systems and robotic transmission components in Pinghu Economic and Technological Development Zone, covering an area of approximately 132 acres [5] - ST United plans to acquire 100% equity of Jiangxi Runtian Industrial Co., Ltd. through a combination of share issuance and cash payment, with the stock resuming trading on May 29, 2025 [6] Group 3 - ST Huaxi signed a significant contract worth approximately 2.084 billion yuan for the repair and installation of a thermal power plant in Iraq, which represents about 80.38% of its latest audited revenue [7] - ST Longjin's stock will enter a delisting arrangement period starting June 6, 2025, following a decision by the Shenzhen Stock Exchange to terminate its listing [8][9] - ST Jiyuan's stock is set to be delisted on May 29, 2025, due to triggering mandatory delisting conditions without entering a delisting arrangement period [10]

Market Overview - The A-share market experienced a five-day decline across major indices, with a total trading volume of 1.03 trillion yuan and nearly 3,500 stocks rising [1] - Market focus shifted towards nuclear power, controllable nuclear fusion, and dairy sectors, while the fertilizer sector saw a decline [1] Stock Performance - A total of 57 stocks hit the daily limit up, with 17 stocks achieving consecutive limit ups, and a limit up rate of 71% (excluding ST and delisted stocks) [3] - Notable performers included Yong'an Pharmaceutical, which achieved 7 limit ups in 11 days, and Binhai Energy with 6 limit ups in 8 days [3] Key Stocks and Their Movements - **Yong'an Pharmaceutical**: Price increased by 10.00% to 24.63 yuan, with a trading volume of 20.52 billion yuan and a turnover rate of 34.68% [15][16] - **Youfu Co., Ltd.**: Price rose by 9.98% to 10.69 yuan, with a trading volume of 22.33 billion yuan and a turnover rate of 21.46% [13][14] - **Shangwei Co., Ltd.**: Price increased by 9.96% to 9.05 yuan, with a trading volume of 14.65 billion yuan and a turnover rate of 26.49% [4] Sector Highlights - The nuclear power sector saw significant interest, with stocks like Shangwei Co., Ltd. and Rongfa Nuclear Power achieving multiple limit ups due to positive market sentiment around nuclear energy [4][10] - The fertilizer and chemical sectors faced downward pressure following an explosion incident at a chemical plant, which affected market sentiment [17] Institutional and Retail Investor Activity - The top net purchases on the trading board were from Snowman Co., Ltd., Youfu Co., Ltd., and Yong'an Pharmaceutical, with net purchases of 175 million yuan, 161 million yuan, and 92.96 million yuan respectively [6] - Conversely, the top net sales were from Guangju Energy, Suzhou Longjie, and Zhongqi Co., Ltd., with net sales of 110 million yuan, 106 million yuan, and 98.75 million yuan respectively [7] Notable News and Developments - Yong'an Pharmaceutical announced a significant increase in its sales volume for 2024, projected to reach 49,700 tons, a year-on-year increase of 16.32% [15] - The controllable nuclear fusion sector is gaining traction, with reports indicating that 26 out of 37 surveyed companies believe the first nuclear fusion unit will be operational by 2035 [9]

智通财经5月28日电，永安药业(002365.SZ)公告称，公司股票交易于2025年5月15日至5月28日连续十个 交易日内收盘价格涨幅偏离值累计超过100%，属于股票交易严重异常波动情形。近期公司股价短期涨 幅较大，已严重偏离公司基本面，存在较高的炒作风险。公司不存在应披露未披露的重大信息。2025年 一季度，公司处于亏损状态。公司特别提醒投资者，注意投资风险，理性决策，审慎投资。 11天7板永安药业：近期公司股价短期涨幅较大 存在较高的炒作风险 ...

证券代码：002365 证券简称：永安药业 公告编号：2025-37 潜江永安药业股份有限公司 关于股票交易严重异常波动暨风险提示公告 （一）经核查，公司前期披露的信息不存在需要更正、补充之处。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 重要风险提示： 1、潜江永安药业股份有限公司（以下简称"公司"，证券简称：永安药业， 证券代码：002365）股票交易于 2025 年 5 月 15 日至 2025 年 5 月 28 日连续十个 交易日内收盘价格涨幅偏离值累计超过 100%，根据深圳证券交易所的有关规定， 属于股票交易严重异常波动情形。 2、近期公司股价短期涨幅较大，已严重偏离公司基本面，存在较高的炒作 风险。公司不存在应披露未披露的重大信息。2025 年一季度，公司处于亏损状 态。公司特别提醒投资者，注意投资风险，理性决策，审慎投资。 3、截至本公告披露时，中证指数有限公司的最新数据显示，公司的静态市 盈率为 106.82，滚动市盈率为 229.74，市净率为 3.34；公司所属中上协行业分 类"医药制造业"的静态市盈率为 28.22，滚动市盈率为 2 ...

Core Viewpoint - Yong'an Pharmaceutical (002365) has experienced a significant abnormal fluctuation in stock trading, with a cumulative closing price increase of over 100% from May 15 to May 28, 2025, indicating a serious deviation from the company's fundamentals and a high risk of speculation [1] Summary by Relevant Sections - Stock Trading Abnormality - The company's stock price has shown a substantial increase over a short period, leading to a classification of severe abnormal trading fluctuations [1] - Financial Performance - In the first quarter of 2025, the company reported a loss, highlighting a disconnect between stock performance and financial fundamentals [1] - Investor Advisory - The company has issued a special reminder for investors to be cautious, make rational decisions, and invest prudently due to the high speculation risk associated with the stock [1]

A股永安药业触及涨停录得11天7板，成交额12.13亿元。 订阅A股涨停捉妖队 +订阅 ...

这几只票暗盘资金正在偷偷流入，立即查看>> 永安药业（002365）触及涨停录得11天7板，成交额12.13亿元。 ...